Quick Answer
Pharma-Bio Serv, Inc. reported Net Income of -$100.5 thousand for fiscal year 2025.
Pharma-Bio Serv, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$100.5K | +87.1% |
| 2024 | -$777.6K | -159.4% |
| 2023 | $1.31M | +30.1% |
| 2022 | $1.01M | +148.2% |
| 2021 | -$2.09M | -201.9% |
| 2020 | $2.05M | -1.7% |
| 2019 | $2.09M | +63.1% |
| 2018 | $1.28M | +190.4% |
| 2017 | -$1.41M | -451.5% |
| 2016 | -$256.6K | -115.8% |
| 2015 | $1.62M | -32.7% |
| 2014 | $2.41M | -50.8% |
| 2013 | $4.91M | +4.7% |
| 2012 | $4.69M | +48.4% |
| 2011 | $3.16M | +749.4% |
| 2010 | $371.9K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $32.9K | +285.0% | +116.1% |
| July 31, 2025 | -$204.2K | +33.9% | -314.2% |
| April 30, 2025 | $95.4K | +144.6% | +1017.1% |
| January 31, 2025 | $8.5K | +103.2% | +102.8% |
| July 31, 2024 | -$309.2K | -158.8% | -44.6% |
| April 30, 2024 | -$213.8K | -152.8% | +21.0% |
| January 31, 2024 | -$270.7K | -163.5% | -151.4% |
| July 31, 2023 | $526.2K | +82.7% | +30.0% |
- Pharma-Bio Serv, Inc. showed an increase of +87.1% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Pharma-Bio Serv, Inc.’s net income has declined by 127.0% (from $371.9 thousand to -$100.5 thousand).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: